Martin B. Brenner's most recent trade in iBio Inc was a trade of 12,336 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on March 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| iBio Inc | Martin B. Brenner | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 19 Mar 2026 | 12,336 | 30,652 (0%) | 0% | 2.0 | 24,919 | Common Stock |
| iBio Inc | Martin B. Brenner | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 479,000 | 479,000 | - | - | Stock Option (right to buy) | |
| iBio Inc | Martin B. Brenner | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2025 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| iBio Inc | B. Brenner Martin | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 230,700 | 230,700 | - | - | Stock Option (right to buy) | |
| iBio Inc | Martin B. Brenner | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 10 Jan 2025 | 9,191 | 18,316 (0%) | 0% | 2.7 | 25,000 | Common Stock |